Jul 9, 2024, 10:44
GLP-1s lowers risk of 10 obesity-associated cancers
Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on X:
“HUGE NEWS: GLP-1s lowered risk of 10 obesity-associated cancers. Compared to insulin, GLP-1s decreased in 10 of 13 cancers – 65% reduction in gallbladder cancer, 59% in pancreatic cancer, and 53% in hepatocellular carcinoma.”
Authors: Lindsey Wang, Rong Xu, David C. Kaelber and Nathan A. Berger.
Source: Ron DePinho/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12